奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603229 奥翔药业

已收盘 07-29 15:00:00

{"stockData":{"symbol":"603229","market":"SH","secType":"STK","nameCN":"奥翔药业","latestPrice":10.54,"timestamp":1753772400000,"preClose":9.58,"halted":0,"volume":48057545,"delay":0,"changeRate":0.1002,"floatShares":830000000,"shares":830000000,"eps":0.2572,"marketStatus":"已收盘","change":0.96,"latestTime":"07-29 15:00:00","open":9.62,"high":10.54,"low":9.45,"amount":493000000,"amplitude":0.1138,"askPrice":0,"askSize":0,"bidPrice":10.54,"bidSize":31971,"shortable":0,"etf":0,"ttmEps":0.2572,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753839000000},"marketStatusCode":5,"adr":0,"adjPreClose":9.58,"symbolType":"stock","openAndCloseTimeList":[[1753752600000,1753759800000],[1753765200000,1753772400000]],"highLimit":10.54,"lowLimit":8.62,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":830297145,"isCdr":false,"pbRate":3.69,"roa":"--","peRate":40.979782,"roe":"5.11%","epsLYR":0.25,"committee":0,"marketValue":8751000000,"turnoverRate":0.0579,"status":0,"floatMarketCap":8751000000},"requestUrl":"/m/hq/s/603229","defaultTab":"news","newsList":[{"id":"2550633443","title":"奥翔药业调整回购价格上限至13.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2550633443","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550633443?lang=zh_cn&edition=full","pubTime":"2025-07-09 17:03","pubTimestamp":1752051835,"startTime":"0","endTime":"0","summary":"7月9日，奥翔药业（603229）发布公告，因2024年度权益分派实施，公司回购价格上限由14元/股调整为13.9元/股，自2025年7月17日起生效。2025年一季度，奥翔药业实现收入3.07亿元，归母净利润1.19亿元。文章来源：财中社原标题：奥翔药业调整回购价格上限至13.9元/股","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709171016a69f104d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709171016a69f104d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2549328816","title":"每周股票复盘：奥翔药业（603229）累计回购股份1999400股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549328816","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549328816?lang=zh_cn&edition=full","pubTime":"2025-07-06 07:24","pubTimestamp":1751757851,"startTime":"0","endTime":"0","summary":"截至2025年7月4日收盘，奥翔药业报收于9.25元，较上周的8.65元上涨6.94%。本周，奥翔药业7月4日盘中最高价报9.39元。奥翔药业当前最新总市值76.8亿元，在化学制药板块市值排名70/150，在两市A股市值排名2100/5149。截至2025年6月30日，公司已累计回购股份1999400股，占公司总股本的0.24%，成交最高价为8.57元/股、最低价为7.52元/股，已支付总金额为15535845.00元。2025年6月，公司未实施股份回购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600001062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2548650258","title":"奥翔药业：公司暂无生产腹膜透析液","url":"https://stock-news.laohu8.com/highlight/detail?id=2548650258","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548650258?lang=zh_cn&edition=full","pubTime":"2025-07-02 15:33","pubTimestamp":1751441585,"startTime":"0","endTime":"0","summary":"有投资者向奥翔药业提问， 公司有生产腹膜透析液吗公司回答表示，投资者您好：公司暂无相关产品。 感谢您对公司的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702154621a4caa0ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702154621a4caa0ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2548078045","title":"奥翔药业：已累计回购0.24%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2548078045","media":"格隆汇","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548078045?lang=zh_cn&edition=full","pubTime":"2025-07-01 15:36","pubTimestamp":1751355366,"startTime":"0","endTime":"0","summary":"格隆汇7月1日丨奥翔药业(603229.SH)公布，截至2025年6月30日，公司通过集中竞价交易方式已累计回购股份1,999,400股，已回购股份占公司总股本的比例为0.24%，成交的最高价为8.57元/股、最低价为7.52元/股，已支付的总金额为15,535,845.00元（不含交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070115362995323f52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070115362995323f52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单？券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计，2025年1—5月，中国创新药企对外授权交易总金额已达455亿美元，超过2024年上半年的交易总额，创新药出海授权交易大爆发。亮眼数据的背后，是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力，正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期，年内大涨明显的创新药企业荣昌生物股价近期大幅回调，从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688181","159992","600998","603716","600867","688068","688506","688488","688317","688166","688117","ONC","600332","688189","600080","600056","688321","688356","688136","600682","688198","603567","688202","688177","600079","688513","688091","688331","688319","601607","600645","688520","688222","600557","600267","603367","600276","688073","688235","688131","600380","600572","603456","600774","603590","603087","600216","600851","603707","600196","600422","600062","600881","688278","BK0239","600351","688505","603127","688163","06160","603259","600521","600789","600200","600222","600721","601089","603229","603998","600420","600535","688336","600513","605199"],"gpt_icon":0},{"id":"2546947022","title":"奥翔药业06月25日主力净流出51.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2546947022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546947022?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:19","pubTimestamp":1750835978,"startTime":"0","endTime":"0","summary":"06月25日, 奥翔药业股价跌0.46%，报收8.74元，成交金额7267.1万元，换手率1.00%，振幅1.37%，量比1.01。奥翔药业今日主力资金净流出51.6万元，上一交易日主力净流入200.3万元。该股近5个交易日下跌0.34%，主力资金累计净流出329.3万元；近20日主力资金累计净流出1.1亿元，其中净流出天数为15日。|06月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|天晟新材|11.04%|#|新力金融|7.66%|#|北方长龙|7.56%|#|...|...|#2482|奥翔药业|-0.01%|奥翔药业所在的化学制药行业，今日主力净流出14.45亿元，行业排名2/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625164010a4bcf71b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625164010a4bcf71b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2545479496","title":"奥翔药业06月23日获主力加仓100.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545479496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545479496?lang=zh_cn&edition=full","pubTime":"2025-06-23 15:19","pubTimestamp":1750663195,"startTime":"0","endTime":"0","summary":"06月23日, 奥翔药业股价涨0.70%，报收8.66元，成交金额5447.4万元，换手率0.76%，振幅2.44%，量比0.64。奥翔药业今日主力资金净流入100.8万元，上一交易日主力净流入67.4万元。该股近5个交易日下跌4.94%，主力资金累计净流出2068.0万元；近20日主力资金累计净流出1.1亿元，其中净流出天数为14日。|06月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|逸豪新材|8.98%|#|大为股份|7.79%|#|C新恒汇|7.30%|#|...|...|#1990|奥翔药业|0.01%|奥翔药业所在的化学制药行业，今日主力净流入11.39亿元，行业排名2/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623163334a4b8842d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623163334a4b8842d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2544169046","title":"奥翔药业收盘下跌1.82%，滚动市盈率33.48倍，总市值71.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544169046","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544169046?lang=zh_cn&edition=full","pubTime":"2025-06-19 19:56","pubTimestamp":1750334184,"startTime":"0","endTime":"0","summary":"6月19日，奥翔药业今日收盘8.61元，下跌1.82%，滚动市盈率PE达到33.48倍，总市值71.49亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均52.37倍，行业中值30.11倍，奥翔药业排名第95位。股东方面，截至2025年3月31日，奥翔药业股东户数30806户，较上次减少11571户，户均持股市值35.28万元，户均持股数量2.76万股。最新一期业绩显示，2025年一季报，公司实现营业收入3.07亿元，同比1.90%；净利润1.19亿元，同比5.97%，销售毛利率61.01%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/19195651177598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2544070924","title":"奥翔药业06月18日遭主力抛售796.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544070924","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544070924?lang=zh_cn&edition=full","pubTime":"2025-06-18 15:21","pubTimestamp":1750231275,"startTime":"0","endTime":"0","summary":"06月18日, 奥翔药业股价跌2.12%，报收8.77元，成交金额9280.6万元，换手率1.27%，振幅2.46%，量比0.79。奥翔药业今日主力资金净流出796.7万元，连续7日净流出，上一交易日主力净流出793.2万元。|06月18日主力加仓幅度排名||#|股票简称|主力净额占比|#|中超控股|8.25%|#|北方长龙|7.16%|#|逸豪新材|5.79%|#|...|...|#3692|奥翔药业|-0.11%|奥翔药业所在的化学制药行业，今日主力净流出13.55亿元，行业排名5/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618170551a710288e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618170551a710288e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":1},{"id":"2544556979","title":"奥翔药业：目前公司正在开发用于治疗缺血性脑卒中的1.1类新药布罗佐喷钠尚待进入Ⅲ期临床相关工作按计划推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2544556979","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544556979?lang=zh_cn&edition=full","pubTime":"2025-06-17 15:36","pubTimestamp":1750145808,"startTime":"0","endTime":"0","summary":"证券之星消息，奥翔药业(603229)06月17日在投资者关系平台上答复投资者关心的问题。投资者提问：公司目前正在开发的用于治疗缺血性脑卒中的1.1类创新药布罗佐喷钠什么时候进入III期临床？创新药形势一片大好，希望公司把握时机，尽快推动！奥翔药业回复：投资者您好：目前公司正在开发用于治疗缺血性脑卒中的1.1类新药布罗佐喷钠尚待进入Ⅲ期临床,相关工作按计划推进。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700018581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2543622470","title":"奥翔药业06月16日遭主力抛售2093.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543622470","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543622470?lang=zh_cn&edition=full","pubTime":"2025-06-16 15:21","pubTimestamp":1750058469,"startTime":"0","endTime":"0","summary":"06月16日, 奥翔药业股价跌0.76%，报收9.11元，成交金额1.1亿元，换手率1.41%，振幅2.18%，量比0.59。奥翔药业今日主力资金净流出2093.4万元，连续5日净流出，上一交易日主力净流出1393.7万元。该股近5个交易日下跌3.39%，主力资金累计净流出5401.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出9405.8万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616171059a70bb882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616171059a70bb882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2543750199","title":"奥翔药业06月13日遭主力抛售1393.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543750199","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543750199?lang=zh_cn&edition=full","pubTime":"2025-06-13 15:20","pubTimestamp":1749799251,"startTime":"0","endTime":"0","summary":"06月13日, 奥翔药业股价跌2.86%，报收9.18元，成交金额1.4亿元，换手率1.87%，振幅3.81%，量比0.79。奥翔药业今日主力资金净流出1393.7万元，连续4日净流出，上一交易日主力净流出361.5万元。|06月13日主力加仓幅度排名||#|股票简称|主力净额占比|#|北方长龙|9.12%|#|通源石油|8.22%|#|海能达|5.30%|#|...|...|#3556|奥翔药业|-0.18%|奥翔药业所在的化学制药行业，今日主力净流出21.18亿元，行业排名7/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613165527a4a700e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613165527a4a700e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2542780396","title":"奥翔药业：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物用于治疗慢性粒细胞白血病急变期","url":"https://stock-news.laohu8.com/highlight/detail?id=2542780396","media":"互动易","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542780396?lang=zh_cn&edition=full","pubTime":"2025-06-10 16:24","pubTimestamp":1749543841,"startTime":"0","endTime":"0","summary":"有投资者向奥翔药业提问， 公司生产的甲磺酸伊马替尼片都有哪些功效？属于创新药吗？公司回答表示，投资者您好：甲磺酸伊马替尼片是全球首个抗肿瘤分子靶向药物，用于治疗慢性粒细胞白血病（CML）急变期、加速期或α-干扰素治疗失败后的慢性期患者、不能手术切除或发生转移的恶性胃肠道间质肿瘤（GIST）患者。甲磺酸伊马替尼制剂商品名为格列卫（Gleevec）。该药品为仿制药。感谢您对公司的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610163048a4a19ab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610163048a4a19ab6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2542395527","title":"奥翔药业：公司将立足于主业持续做好自身经营加快产品销售布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2542395527","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542395527?lang=zh_cn&edition=full","pubTime":"2025-06-10 16:06","pubTimestamp":1749542770,"startTime":"0","endTime":"0","summary":"证券之星消息，奥翔药业(603229)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：举而不坚，坚而不久，自己做药的应该开发一款自己服用的药！是吗董秘？奥翔药业回复：投资者您好：公司将立足于主业，持续做好自身经营，加快产品销售布局，不断研发新技术、开发新产品，努力开拓新的业绩增长点，使公司得以持续、健康、稳定的发展。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000022279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2542245386","title":"又有积极信号出现！中办、国办重磅发布，创新药逻辑再被强化","url":"https://stock-news.laohu8.com/highlight/detail?id=2542245386","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542245386?lang=zh_cn&edition=full","pubTime":"2025-06-09 19:01","pubTimestamp":1749466862,"startTime":"0","endTime":"0","summary":"完善基本医疗保险药品目录调整机制，制定出台商业健康保险创新药品目录，更好满足人民群众多层次用药保障需求。中办、国办重磅发布今天下午，中共中央办公厅、国务院办公厅发布《关于进一步保障和改善民生 着力解决群众急难愁盼的意见》，意见指出:一要增强社会保障公平性。创新药逻辑再被强化从上述政策来看，创新药的逻辑再度被强化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506091857119514a7b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506091857119514a7b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603998","688799","688321","688687","BK0012","603456","600521","603367","688068","688202","603229","688117","688710","BK0185","603590","688513","688189","600196","688073","BK0201","600557","BK0188","688506","BK0028","600851","603707","BK0070","600267","688658","159992","600881","688566","600867","688488","688177","600513","688091"],"gpt_icon":0},{"id":"2542046418","title":"奥翔药业06月09日主力净流入1299.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2542046418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542046418?lang=zh_cn&edition=full","pubTime":"2025-06-09 15:19","pubTimestamp":1749453585,"startTime":"0","endTime":"0","summary":"06月09日, 奥翔药业股价涨4.31%，报收9.43元，成交金额3.0亿元，换手率3.88%，振幅7.08%，量比1.03。奥翔药业今日主力资金净流入1299.6万元，上一交易日主力净流出1510.0万元。该股近5个交易日上涨4.20%，主力资金累计净流出7402.4万元；近20日主力资金累计净流出4551.9万元，其中净流出天数为13日。|06月09日主力加仓幅度排名||#|股票简称|主力净额占比|#|跨境通|12.02%|#|元隆雅图|8.74%|#|康力源|6.71%|#|...|...|#747|奥翔药业|0.17%|奥翔药业所在的化学制药行业，今日主力净流入3.81亿元，行业排名13/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609165542a4a01525&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609165542a4a01525&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2541830229","title":"奥翔药业06月06日遭主力抛售1510.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541830229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541830229?lang=zh_cn&edition=full","pubTime":"2025-06-06 15:20","pubTimestamp":1749194428,"startTime":"0","endTime":"0","summary":"06月06日, 奥翔药业股价跌0.99%，报收9.04元，成交金额1.2亿元，换手率1.63%，振幅2.30%，量比0.45。奥翔药业今日主力资金净流出1510.0万元，连续4日净流出，上一交易日主力净流出2435.4万元。该股近5个交易日上涨6.23%，主力资金累计净流出3944.3万元；近20日主力资金累计净流出5487.6万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606165931a49ca6cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606165931a49ca6cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2541047289","title":"奥翔药业06月05日遭主力抛售2435.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541047289","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541047289?lang=zh_cn&edition=full","pubTime":"2025-06-05 15:19","pubTimestamp":1749107997,"startTime":"0","endTime":"0","summary":"06月05日, 奥翔药业股价跌1.40%，报收9.13元，成交金额1.7亿元，换手率2.25%，振幅3.13%，量比0.68。奥翔药业今日主力资金净流出2435.4万元，连续3日净流出，上一交易日主力净流出1940.9万元。该股近5个交易日上涨9.08%，主力资金累计净流出2934.0万元；近20日主力资金累计净流出3974.2万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605164052a6fb77c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605164052a6fb77c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2540725599","title":"奥翔药业：目前公司正在开发用于治疗缺血性脑卒中的1.1类新药布罗佐喷钠尚待进入Ⅲ期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2540725599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540725599?lang=zh_cn&edition=full","pubTime":"2025-06-03 16:15","pubTimestamp":1748938509,"startTime":"0","endTime":"0","summary":"证券之星消息，奥翔药业(603229)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：公司开发的创新药都有哪些，请给投资者们详细说明一下！谢谢！奥翔药业回复：投资者您好：目前公司正在开发用于治疗缺血性脑卒中的1.1类新药布罗佐喷钠尚待进入Ⅲ期临床。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060300019974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2539219168","title":"异动快报：奥翔药业（603229）5月30日11点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2539219168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539219168?lang=zh_cn&edition=full","pubTime":"2025-05-30 11:15","pubTimestamp":1748574924,"startTime":"0","endTime":"0","summary":"证券之星5月30日盘中消息，11点14分奥翔药业触及涨停板。目前价格9.36，上涨9.99%。其所属行业化学制药目前上涨。领涨股为华纳药厂。该股为创新药，医药，化学原料药概念热股，当日创新药概念上涨3.09%，医药概念上涨2.06%，化学原料药概念上涨2.03%。5月29日的资金流向数据方面，主力资金净流出635.62万元，占总成交额9.68%，游资资金净流出611.7万元，占总成交额9.32%，散户资金净流入1247.32万元，占总成交额19.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053000013506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603229","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753792635738,"stockEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.1194},{"period":"3month","weight":0.2398},{"period":"6month","weight":0.1458},{"period":"1year","weight":0.3772},{"period":"ytd","weight":-0.0308}],"compareEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":0.0507},{"period":"3month","weight":0.0947},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0734}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江奥翔药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"30806人(较上一季度减少27.30%)","perCapita":"26952股","listingDate":"2017-05-09","address":"浙江省台州市临海市化学原料药基地临海园区东海第四大道5号","registeredCapital":"83029万元","survey":"　　浙江奥翔药业股份有限公司的主营业务是从事制剂、特色原料药及医药中间体的研发、生产与销售，以及为客户提供定制生产和研发业务。公司的主要产品是肝病类、抗菌类、心脑血管类、前列腺素类、高端氟产品类、痛风类、抗肿瘤类、神经系统类、其他类。目前，公司的成熟产品已有双环醇、恩替卡韦、西他沙星、泊沙康唑、非布司他、奈必洛尔、米格列醇等。经过多年化学合成的生产经验积累和技术工艺研发创新，公司形成了以合成装备完整先进、合成工艺成熟丰富、产业化能力强以及质量控制规范等为特征的化学原料药生产制造能力优势。","listedPrice":7.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥翔药业(603229)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥翔药业,603229,奥翔药业股票,奥翔药业股票老虎,奥翔药业股票老虎国际,奥翔药业行情,奥翔药业股票行情,奥翔药业股价,奥翔药业股市,奥翔药业股票价格,奥翔药业股票交易,奥翔药业股票购买,奥翔药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥翔药业(603229)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}